KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Asset Writedowns and Impairment (2020 - 2026)

Biogen has reported Asset Writedowns and Impairment over the past 11 years, most recently at $4.8 million for Q1 2026.

  • For Q1 2026, Asset Writedowns and Impairment fell 34.25% year-over-year to $4.8 million; the TTM value through Mar 2026 reached $61.2 million, up 53.0%, while the annual FY2025 figure was $29.2 million, 51.5% down from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 was $4.8 million at Biogen, down from $52.9 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $275.0 million in Q1 2022 and troughed at -$62.1 million in Q4 2023.
  • A 5-year average of $69.5 million and a median of $19.8 million in 2023 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 2210.92% in 2022 and later plummeted 122.58% in 2023.
  • Year by year, Asset Writedowns and Impairment stood at $275.0 million in 2022, then crashed by 122.58% to -$62.1 million in 2023, then skyrocketed by 120.13% to $12.5 million in 2024, then soared by 323.2% to $52.9 million in 2025, then crashed by 90.93% to $4.8 million in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for BIIB at $4.8 million in Q1 2026, $52.9 million in Q4 2025, and $3.5 million in Q2 2025.